T he incidence and prevalence of inflammatory bowel disease (IBD) continues to change worldwide, and rates of IBD have increased with time. 1 Although the highest reported rates are in North America, the United Kingdom, Northern Europe, and Australia, higher incidence rates are being reported in developing countries as these regions become more industrialized. 1 The cause for this trend in unknown; however, environmental factors, such as sanitation, diet, or microbial exposure, have been hypothesized to be involved. [1] [2] [3] Population-based studies, which allow for complete case ascertainment and follow-up data, are important in studying these trends. A population-based cohort of Olmsted County, Minnesota residents with Crohn's disease (CD) and ulcerative colitis (UC) has been studied since 1935. [4] [5] [6] [7] [8] [9] [10] Between 1935 and 1975, there was a significant increase in UC incidence, 4 and rates stabilized thereafter through 2000. 8, 9 Higher UC incidence rates have been significantly associated with male gender and younger age group. 9 Similarly, age-and sex-adjusted incidence rates of CD increased after 1940 and peaked in the 1964-1973 time period. 7 These rates continued to increase through 2000. 9 The descriptive epidemiology of the Olmsted County population-based cohort of patients with IBD was last updated through 2000. 9 Between 1940 and 2000, the age-and sex-adjusted annual incidence rates for CD and UC were reported at 8.8 cases per 100,000 person-years and 7.9 cases per 100,000, respectively. 9 The prevalence of UC was noted to have decreased by 7% and the prevalence of CD increased by 31% between 1991 and 2000. 9 This study aims to update the incidence and prevalence of CD and UC through 2011 in this population-based cohort of patients with IBD. Further study of this cohort of patients may help elucidate the cause for changing epidemiologic trends given the distinct patient population that can easily be studied.
Methods

Rochester Epidemiology Project
The Rochester Epidemiology Project is a unique medical records linkage system developed in the 1950s and supported by the National Institutes of Health. It exploits the fact that virtually all of the health care for the residents of Olmsted County is provided by 2 organizations: Mayo Medical Center, consisting of Mayo Clinic and its 2 affiliated hospitals (Rochester Methodist and Saint Mary's); and Olmsted Medical Center, consisting of a smaller multispecialty clinic and its affiliated hospital (Olmsted Community Hospital). In any 4-year period, more than 95% of county residents are examined at either one of the 2 health care systems. [11] [12] [13] Diagnoses generated from all outpatients visits, emergency room visits, hospitalizations, nursing home visits, surgical procedures, autopsy examinations, and death certificates are recorded in a central diagnostic index. Thus, it is possible to identify virtually all diagnosed cases of a given disease for which patients sought medical attention.
Case Ascertainment
The resources of the Rochester Epidemiology Project were used to identify all residents of Olmsted County who were diagnosed with either CD or UC from 1970 through 2010. Previously used definitions for CD and UC diagnoses were used in this study. [7] [8] [9] Cases of UC were diagnosed based on finding the following criteria on 2 occasions separated by at least 6 months: diffusely granular or friable colonic mucosa on endoscopy; and continuous mucosal involvement based on endoscopy or barium studies. 9 CD cases were identified based on at least 2 of the following criteria found on 2 occasions, separated by at least 2 months: (1) history of abdominal pain, diarrhea, weight loss, malaise, and/or rectal bleeding; (2) endoscopic findings of linear ulceration, mucosal cobblestoning, skip areas, or perianal disease; (3) radiologic findings of fistula, stricture, mucosal cobblestoning, or ulceration; (4) laparotomy appearance of "creeping fat," bowel wall induration, and mesenteric lymphadenopathy; or (5) histologic findings of transmural inflammation and/or epithelioid granulomas. 9 Medical records of previously identified cases of CD and UC were reviewed to ensure that diagnoses were accurate. The following data were recorded: baseline demographic data including date of birth and sex; date of CD or UC diagnosis; and county residence status at date of diagnosis, January 1, 2011, and date of last follow-up.
Statistical Analysis
Incidence rates for CD and UC were obtained by dividing the number of people diagnosed with CD or UC by the total population at risk. Rates were age-and sexadjusted to the 2010 US census for whites.
14 County residents who met diagnostic criteria on the preset date of January 1, 2011, were identified as prevalence cases, and this was estimated similarly to the incidence rates. Poisson regression analysis was used to determine if incidence rates were significantly associated with age, sex, or year of diagnosis. The adjusted prevalence of CD and UC in Olmsted County were used to extrapolate the number of US residents with CD and UC using the 2010 US census.
Results
A total of 893 patients with IBD were identified during the 1970-2010 period; there were 410 patients with CD and 483 patients with UC ( Table 1 ). The median age at diagnosis of CD was 29.5 years (range, 3.8-93.1) and that of UC was 34.9 (1.2-94.1). A total of 209 patients with CD were female (51%), whereas 272 patients with UC were male (56%). The diagnosis of CD and UC was most common in the 20-to-29-year-old age group.
Incidence
The overall age-and sex-adjusted incidence rates for CD and UC were 8.7 and 10.7 per 100,000 person-years, respectively, for the entire 1970-2010 period. The adjusted incidence rates for CD and UC in 2000-2010 were 10.7 and 12.2 per 100,000 person-years, respectively ( Figure 1 ). Age-specific rates for both CD and UC were estimated (Table 2) . Adjusted rates by decade were estimated for CD and UC (Table 3) . Crohn's Disease
The age-and sex-adjusted incidence rates for CD increased during the study period of 1970 through 2010. Younger age (P < .001) and a later calendar year of diagnosis (P ¼ .003) were significantly associated with a higher incidence of CD in Poisson regression analysis. The 20-to-29-year-old age group had the highest crude incidence rate of CD (16.6 cases per 100,000 person-years), whereas the 1-to-19-year-old age group had the lowest (6.5 per 100,000) ( Table 2 ). Overall incidence rates for CD were similar in men and women, and incidence rates for both groups sharply decreased after the age of 29 years (Figure 2A ). About two-thirds of cases of CD were diagnosed younger than the age of 40 years. In the Poisson regression, sex was not significantly associated with higher incidence rates of CD (P ¼ .93). The age-adjusted incidence rate for females was 8.6 per 100,000 personyears and that of males was 8.9 per 100,000 person-years.
Ulcerative Colitis
The age-and sex-adjusted incidence rates for UC tended to increase during the 1970-2010 study period. In the Poisson regression analysis, sex was associated with higher incidence rates of UC (P < .001), with men having consistently higher incidence rates than women across all age groups ( Figure 2B ). The age-adjusted UC incidence rate for males was 12.8 cases per 100,000 person-years and that for women was 8.8 per 100,000. Neither age (P ¼ .35) nor calendar year of diagnosis (P ¼ .06) were associated with a higher incidence of UC in the Poisson analysis. The highest crude incidence rate of UC was observed in the 20-to-29-year-old age group (18.7 cases per 100,000 person-years), whereas the lowest rate was seen in the 1-to-19 age group (4.0 per 100,000) ( Table 2) .
Prevalence
There were a total of 380 county residents with CD and 435 with UC on January 1, 2011. Therefore, the ageand sex-adjusted prevalence for CD and UC were 246.7 cases per 100,000 persons and 286.3 per 100,000 persons, respectively. The prevalence for CD and UC in 2001 had been 174 and 214 cases per 100,000 persons, respectively. 9 Thus, the prevalence of CD has increased by 41% and that of UC by 33% during the intervening 10 years (Figure 3) . 
Discussion
This study of the descriptive epidemiology of CD and UC in a population-based cohort of Olmsted County, Minnesota patients between 1970 and 2010 showed an increase in CD and UC incidence and prevalence. Whereas the incidence of CD was 8.8 cases per 100,000 person-years and that of UC was 7.9 per 100,000 in 1990-2000, the rates increased to 10.7 per 100,000 and 12.2 per 100,000 for CD and UC, respectively, in the 2000-2010 study period (Figure 1 ). We found that younger age and later calendar years of diagnosis were significantly associated with CD incidence; however, only male gender was associated with a higher incidence rate of UC. The age-and sex-adjusted prevalence of CD was 246.7 cases per 100,000 persons and that of UC was 286.2 per 100,000 on January 1, 2011.
When compared with January 1, 2000 (214 cases per 100,000 persons), 9 the prevalence was 34% higher for UC in 2011 (Figure 3 ). In comparison, there was a 41% increase in CD prevalence between 2001 (174 cases per 100,000) and 2011, 9 When we had previously compared the prevalence of UC and CD between 1991 and 2001, there had been a 31% increase in CD prevalence and minimal change in UC prevalence. 9 The increasing prevalence of CD and UC may well be caused in part by patients living longer with the disease, because they usually are diagnosed at a younger age, and have a normal or near-normal life expectancy on average. This concept of "compounding prevalence" has been previously noted. 15 Multiple studies have assessed the epidemiologic trends of CD and UC in various countries. [16] [17] [18] [19] [20] [21] Canadian population-based studies have reported some of the highest rates of IBD world-wide. 18, 22, 23 In Ontario, Benchimol et al 22 found an increase in the incidence and prevalence of CD and UC between 1998 and 2008, with a particularly significant increase in the pediatric population (ie, age <18 years). During this time period, the incidence rate of CD increased from 9.6 to 12.1 cases per 100,000 person-years, and that of UC increased from 10.7 to 12.1 per 100,000. 22 The most recent incidence rate for UC in Olmsted County during 2000-2010 was comparable with that of Ontario, whereas the CD incidence rate in Olmsted County was slightly lower.
There were a few differences between the study by Benchimol et al 22 and ours. Benchimol et al 22 had a larger sample size, and they used administrative data, such as International Classification of Disease-9 codes, billing claims, and medication prescription data. Their means of identifying patients with IBD by these methods were validated. The validation algorithm for children with IBD had a sensitivity of 89.6%-91.1% and a specificity of 99.5%-99.9%, and the algorithm for adults with IBD had lower sensitivity (76.8%-92.3%) and specificity (96.2%-99.1%). 22 However, our study was a population-based cohort in which the medical records of each potential IBD case was manually reviewed for predetermined diagnostic criteria, rather than relying on administrative data.
A pediatric population-based study from Iceland examined the incidence of CD and UC in children younger than 16 years. 16 Between 1951 and 2000, the incidence rate of CD increased from 0.2 cases per 100,000 personyears to 2.3 per 100,000, and the rate of UC increased from 1.1 per 100,000 to 2.4 per 100,000. 16 In the 2001-2010 study period, the incidence rates declined slightly to 2.3 cases per 100,000 person-years for CD and 2.4 per 100,000 for UC. 16 In comparison, among those younger than 19 years of age in Olmsted County, the overall 1970-2010 incidence of CD was 6.4 cases per 100,000 person-years and that of UC was 4.0 per 100,000. The cause for the higher incidences of CD and UC at younger ages in Olmsted County is unclear; one might speculate that environmental factors may play a role, but these apparent differences may also be caused by different age cutoffs.
In contrast to other studies that have shown increasing incidence rates for CD and UC, a populationbased study from the Canadian maritime province of Nova Scotia showed a decrease in CD and UC incidence between 1996 and 2009. 23 Age-adjusted incidence rates for CD and UC decreased from 27.4 cases per 100,000 person-years to 17.7 per 100,000, and from 21 per 100,000 to 16.7 per 100,000, respectively, during the study period. 23 Similar to the study by Benchimol et al, 22 diagnoses of IBD were made based on a validated database scoring system: administrate data, such as International Classification of Disease-9 codes taken together with physician billing claims and, if hospitalized, discharge diagnoses. 23, 24 The reason for the declining incidence in Nova Scotia is unclear. However, the number of diagnoses may have been underestimated if patients were not hospitalized or seeking health care, such as in the case of mild disease as noted by the authors.
Globally, however, 75% of CD studies and 60% of UC studies have shown a statistically significant increase in incidence. 1 Our study is in keeping with this global trend. 1 Although western nations have the highest incidence of CD and UC, previously low-incidence regions, such as Asia, have recently had increasing rates of CD and UC. 19, 25, 26 The reasons for increasing incidence of CD and UC are relatively unknown. It has been noted that those who emigrate from a low prevalence area to a higher prevalence region are at increased risk of developing IBD, thereby suggesting an environmental etiology. 1 IBD is more prevalent in urban regions compared with rural areas, and in industrial nations compared with developing regions. 1 These data suggest that changes in diet, lifestyle, and sanitation, among others, may be the particular environmental causes. 3, 27 However, further investigation must be undertaken to fully elucidate this.
The increased incidence of CD and UC leads to an increased economic burden with higher health care utilization. Because many patients are diagnosed with IBD at a young age, this leads to lifelong medical treatment and loss of productivity at work. It is estimated that days of work lost and disability amounts to about 50% of the cost. 28 Not only is the higher healthcare burden caused by medications, procedures, and hospitalizations, but this may also be due to an aging population of patients with IBD who are living longer with the disease as evidenced by the "compounding prevalence" of the disease. 15 The strength of this study is that all case ascertainment was based on clinical diagnoses and medical record review rather than on administrative data. All available patient data were reviewed because of the linked diagnostic index. Because greater than 95% of Olmsted County residents receive their health care at either Mayo Medical Center or Olmsted Medical Center, we were able to capture essentially all patients with a diagnosis of either CD and UC. 29 Conversely, there are a few limitations of this study, similar to those that have been discussed in previous studies of this cohort. 9 There may be limited follow-up in some cases, especially in those instances when patients moved out of the county. The population of Olmsted County is relatively small. 21, 22 Finally, the population of Olmsted County is not as diverse racially and ethnically as much of the United States; for example, as of the 2010 US census, about 83.4% of Olmsted County residents were non-Hispanic white. Given the fairly homogenous population, generalizability of these data may not be possible in populations with disparate racial makeup.
In summary, the incidence rates of CD and UC in Olmsted County continued to rise over the past decade. The combined prevalence of CD and UC in Olmsted County in 2011 was more than 530 cases per 100,000. Stated another way, about 1 in 200 Olmsted County residents in 2011 had IBD. Finally, extrapolating the adjusted prevalence to the current US census, there are approximately 785,000 US residents with CD and 910,000 with UC, for a total of about 1.6 million US residents with IBD. However, these figures should be considered a rough approximation of the true number of CD and UC cases in the United States, because our adjusted prevalence was based on the 2010 US white population. Future aims include using this updated cohort as a basis for studying the etiology of these trends.
